Jagannath S - Search Results

1

Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach.

Laganà A, Beno I, Melnekoff D, Leshchenko V, Madduri D, Ramdas D, Sanchez L, Niglio S, Perumal D, Kidd BA, Miotto R, Shaknovich R, Chari A, Cho HJ, Barlogie B, Jagannath S, Dudley JT, Parekh S. Laganà A, et al. Among authors: jagannath s. JCO Precis Oncol. 2018;2018:PO.18.00019. doi: 10.1200/PO.18.00019. Epub 2018 Aug 8. JCO Precis Oncol. 2018. PMID: 30706044 Free PMC article.

2

Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function.

Jagannath S, Barlogie B, Berenson JR, Singhal S, Alexanian R, Srkalovic G, Orlowski RZ, Richardson PG, Anderson J, Nix D, Esseltine DL, Anderson KC; SUMMIT/CREST Investigators. Jagannath S, et al. Cancer. 2005 Mar 15;103(6):1195-200. doi: 10.1002/cncr.20888. Cancer. 2005. PMID: 15690325 Free article.

3

Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma.

Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Hideshima T, Xiao H, Esseltine D, Schenkein D, Anderson KC; SUMMIT Investigators. Richardson PG, et al. Among authors: jagannath s. Blood. 2005 Nov 1;106(9):2977-81. doi: 10.1182/blood-2005-02-0691. Epub 2005 Jul 14. Blood. 2005. PMID: 16020506 Free article. Clinical Trial.

4

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial.

Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin DH, Rajkumar SV, Srkalovic G, Alsina M, Anderson KC. Richardson PG, et al. Among authors: jagannath s. Cancer. 2006 Mar 15;106(6):1316-9. doi: 10.1002/cncr.21740. Cancer. 2006. PMID: 16470606 Free article. Clinical Trial.

5

Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone.

Jagannath S, Richardson PG, Barlogie B, Berenson JR, Singhal S, Irwin D, Srkalovic G, Schenkein DP, Esseltine DL, Anderson KC; SUMMIT/CREST Investigators. Jagannath S, et al. Haematologica. 2006 Jul;91(7):929-34. Haematologica. 2006. PMID: 16818280 Clinical Trial.

6

Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma.

Jagannath S, Barlogie B, Berenson JR, Siegel DS, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Esseltine DL, Anderson KC. Jagannath S, et al. Br J Haematol. 2008 Nov;143(4):537-40. doi: 10.1111/j.1365-2141.2008.07359.x. Epub 2008 Sep 6. Br J Haematol. 2008. PMID: 18783399 Free article. Clinical Trial.

7

Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients.

Lendvai N, Gnjatic S, Ritter E, Mangone M, Austin W, Reyner K, Jayabalan D, Niesvizky R, Jagannath S, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. Lendvai N, et al. Among authors: jagannath s. Cancer Immun. 2010 Jan 29;10:4. Cancer Immun. 2010. PMID: 20108890 Free PMC article.

8

Proteasome inhibition and its therapeutic potential in multiple myeloma.

Chari A, Mazumder A, Jagannath S. Chari A, et al. Among authors: jagannath s. Biologics. 2010 Sep 28;4:273-87. doi: 10.2147/BTT.S3419. Biologics. 2010. PMID: 21116326 Free PMC article.

9

Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.

Dong H, Yang HS, Jagannath S, Stephenson CF, Brenholz P, Mazumder A, Chari A. Dong H, et al. Among authors: jagannath s. Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):366-74. doi: 10.1016/j.clml.2012.05.003. Epub 2012 Jun 1. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22658896

10

Safety and efficacy of triplet regimens in newly diagnosed light chain amyloidosis.

Chari A, Barley K, Jagannath S, Osman K. Chari A, et al. Among authors: jagannath s. Clin Lymphoma Myeloma Leuk. 2013 Feb;13(1):55-61. doi: 10.1016/j.clml.2012.09.011. Epub 2012 Oct 24. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23098888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

509 results

Search Page

Filters